Metraipolis › archive › dc_98ccb67dddb4
Case Report: Iparomlimab and Tuvonralimab-based therapy for epithelioid malignant peritoneal mesothelioma: a three-case series — Europe PMC PMID:42755633
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42755633
- DOI
- 10.3389/fonc.2026.1914733
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T06:01:43.983Z
- SHA-256 of the archived text
38c144231914b2c890676d2ca2ced673a44b0cbcf560ae21d16f03c37baf8730- Stable URL of this page
https://metraipolis.com/documento/dc_98ccb67dddb4
How to cite
Case Report: Iparomlimab and Tuvonralimab-based therapy for epithelioid malignant peritoneal mesothelioma: a three-case series — Europe PMC PMID:42755633 — Europe PMC (en), https://europepmc.org/article/MED/42755633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98ccb67dddb4 (Metraipolis archive dc_98ccb67dddb4, sha256 38c144231914b2c890676d2ca2ced673a44b0cbcf560ae21d16f03c37baf8730)
BibTeX
@misc{dc98ccb67dddb4,
title = {Case Report: Iparomlimab and Tuvonralimab-based therapy for epithelioid malignant peritoneal mesothelioma: a three-case series — Europe PMC PMID:42755633},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42755633},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98ccb67dddb4; sha256 38c144231914b2c890676d2ca2ced673a44b0cbcf560ae21d16f03c37baf8730},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755633. Agents can read the archived copy with the MCP tool read_document.